Is providing uncertainty intervals in treatment ranking helpful in a network meta-analysis?

[1]  A E Ades,et al.  Evidence synthesis assumes additivity on the scale of measurement: response to "Rank reversal in indirect comparisons" by Norton et al. , 2013, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[2]  M. Galván-Banqueri,et al.  Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis. , 2015, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

[3]  Areti Angeliki Veroniki,et al.  The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes. , 2016, Journal of clinical epidemiology.

[4]  Gordon H. Guyatt,et al.  Approaches to interpreting and choosing the best treatments in network meta-analyses , 2017, Systematic Reviews.

[5]  F. Zagmutt,et al.  Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and Rasagiline , 2012, The International journal of neuroscience.

[6]  H. Chu,et al.  The Impact of Excluding Trials from Network Meta-Analyses – An Empirical Study , 2016, PloS one.

[7]  Andrew Thomas,et al.  The BUGS project: Evolution, critique and future directions , 2009, Statistics in medicine.

[8]  Gerta Rücker,et al.  Ranking treatments in frequentist network meta-analysis works without resampling methods , 2015, BMC Medical Research Methodology.

[9]  Kristian Thorlund,et al.  The effects of excluding treatments from network meta-analyses: survey , 2013, BMJ : British Medical Journal.

[10]  Panagiota Spyridonos,et al.  Graphical Tools for Network Meta-Analysis in STATA , 2013, PloS one.

[11]  Joseph Beyene,et al.  Bias in identification of the best treatment in a Bayesian network meta-analysis for binary outcome: a simulation study , 2014, Clinical epidemiology.

[12]  Ian R. White,et al.  Multivariate Random-effects Meta-regression: Updates to Mvmeta , 2011 .

[13]  Morgen M. Miller,et al.  Rank reversal in indirect comparisons. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[14]  Philippe Ravaud,et al.  Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials , 2016, Annals of Internal Medicine.

[15]  Deborah M Caldwell,et al.  Novel presentational approaches were developed for reporting network meta-analysis. , 2014, Journal of clinical epidemiology.

[16]  Wasifa Zarin,et al.  Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015. , 2017, Journal of clinical epidemiology.

[17]  Shannon Cope,et al.  Quantitative summaries of treatment effect estimates obtained with network meta-analysis of survival curves to inform decision-making , 2013, BMC Medical Research Methodology.

[18]  Julian P T Higgins,et al.  Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis , 2014, BMJ Open.

[19]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[20]  Joseph C Cappelleri,et al.  Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. , 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[21]  Neil Hawkins,et al.  No study left behind: a network meta-analysis in non-small-cell lung cancer demonstrating the importance of considering all relevant data. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[22]  Sharon E. Straus,et al.  Characteristics and knowledge synthesis approach for 456 network meta-analyses: a scoping review , 2017, BMC Medicine.

[23]  Julian P T Higgins,et al.  Evaluation of inconsistency in networks of interventions. , 2013, International journal of epidemiology.

[24]  Georgia Salanti,et al.  Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.

[25]  Jingpu Shi,et al.  Efficacy and Safety of Therapies for Acute Ischemic Stroke in China: A Network Meta-Analysis of 13289 Patients from 145 Randomized Controlled Trials , 2014, PloS one.

[26]  V. Cornelius,et al.  Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple‐treatments meta‐analysis , 2014, Acta psychiatrica Scandinavica.

[27]  A. Tricco,et al.  Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes , 2017, BMC Medicine.

[28]  Kristian Thorlund,et al.  The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.

[29]  Philippe Ravaud,et al.  Reporting of results from network meta-analyses: methodological systematic review , 2014, BMJ : British Medical Journal.

[30]  B. Davis,et al.  Cardiovascular and Renal Outcomes of Renin–Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses , 2016, PLoS medicine.

[31]  Andrea Cipriani,et al.  Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis , 2011, The Lancet.

[32]  A. Tricco,et al.  Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis , 2017, BMJ Open.